DYNLRB2 and ductal breast carcinoma in situ: Mutations in DYNLRB2 have been associated with intraductal carcinoma of the breast, hypercholesterolemia, Jeune syndrome, short rib polydactyly type III, asphyxiating thoracic dystrophy, and abnormal cranial development in embryonic infants (Liao et al., 2012; Li et al., 2019; Pina et al., 2023; Asante et al., 2014).